| ALPHA,BETA-METHYLENEADENOSINE 5'-DIPHOSPHATE |
腺苷5'-(Α,Β-亚甲基)二磷酸 |
3768-14-7 |
| Quetiapine IMpurity [2-(2-Piperazin-1-yl)ethoxy)ethanol] |
喹硫平杂质 |
2206135-50-2 |
| Quetiapine iMpurity |
富马酸喹硫平杂质 |
2206135-48-8 |
| 2-[4-(2-Methylpropyl)phenyl] ethanol |
布洛芬EP杂质H |
2143535-25-3 |
| (S)-N-(1-AMino-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide |
硼替佐米杂质 |
289472-80-6 |
| N-[2-Methyl-4-[2-(2-methylphenyl)diazenyl]phenyl]-2-furancarboxamide |
N-[2-Methyl-4-[2-(2-methylphenyl)diazenyl]phenyl]-2-furancarboxamide |
289494-16-2 |
| 2-[3-(S)-[3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl]-3-hydroxypropyl]phenyl-2-propanol |
孟鲁司特钠杂质 |
287930-77-2 |
| Palonosetron impurity |
(R)-N-(((R)-1,2,3,4-四氢萘-1-基)甲基)奎宁环-3-胺 |
2216746-63-1 |
| Topiroxostat Impurity |
托匹司他杂质 |
2044702-36-3 |
| NSC-703786 |
4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯胺 |
260443-89-8 |
| Fesoterodinefumarate |
富马酸非索罗定 |
286930-03-8 |
| PELITINIB |
培利替尼 |
257933-82-7 |
| AKT/SKG SUBSTRATE PEPTIDE |
蛋白激酶B(抗原) |
276680-69-4 |
| (S)-2-ETHOXY-3-[4-[2-(4-METHANESULFONYLOXY-PHENYL)-ETHOXY]-PHENYL]-PROPIONIC ACID |
(S)-2-乙氧基-3-{4-[2-(4-甲磺酰基苯基)-乙氧基-苯基]-丙酸 |
251565-85-2 |
| (SP-4-2)-[(1R,2R)-1,2-Cyclohexanediamine-kN,kN']bis(tetradecanoato-kO)platinum monohydrate |
米铂水合物 |
250159-48-9 |
| Varenicline |
伐伦克林 |
249296-44-4 |
| N1-Losartanyl-losartan (Losartan IMpurity) |
氯沙坦杂质L |
230971-71-8 |
| Orantinib (SU6668) |
orantinib |
252916-29-3 |
| 6-aMino-9-benzyl-2-(2-Methoxyethoxy)-9H-purin-8-ol |
6-氨基-7,9-二氢-2-(2-甲氧基乙氧基)-9-(苯甲基)-8H-嘌呤-8-酮 |
226907-52-4 |
| LB 42708 |
2MG |
226929-39-1 |
